Cold virus turned cancer killer: new trial launches
Disease control
Recruiting now
This early-phase trial tests a new drug called ATTR-01 in adults with certain solid tumors that have not responded to standard treatments. ATTR-01 is a modified cold virus designed to infect and multiply only in cancer cells, delivering an immune-boosting therapy to help the body…
Phase: PHASE1, PHASE2 • Sponsor: Accession Therapeutics Limited • Aim: Disease control
Last updated May 26, 2026 11:26 UTC